Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Remimazolam on Incidence of Hypoxia During Sedated Transvaginal Oocyte Retrieval: A Multicenter Randomized Controlled Trial.

NCT07335536 is registered in ClinicalTrials.gov with Diansan Su as lead sponsor.

NCT NCT07335536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07335536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Remimazolam on Incidence of Hypoxia During Sedated Transvaginal Oocyte Retrieval: A Multicenter Randomized Controlled Trial.
Lead sponsor
Diansan Su
Phase
Not applicable
Overall status
Recruiting
Start date
October 20, 2025
Completion date
December 30, 2026
Enrollment
400 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxia, infertility, infertility assisted reproductive technology